Brief: Gene Techno Science commences phase III clinical trial for biosimilars in ophthalmology

Kidswell Bio

09/11/2017 03:59

Nov 9 (Reuters) - Gene Techno Science Co Ltd  4584.T  
    
    * Says it commenced the phase III clinical trial for 
biosimilars 
in ophthalmology, which is a joint work between the co and Senju 
Pharmaceutical Co Ltd  
 
    Source text in Japanese: https://goo.gl/jbvWVM 
    Further company coverage: 4584.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: Tingting.liu@thomsonreuters.com@reuters.net))